Medical College, Yangzhou University, Yangzhou, China.
Department of Interventional Radiology, Jiangyin people's hospital, Jiangyin, China.
Brachytherapy. 2021 May-Jun;20(3):638-644. doi: 10.1016/j.brachy.2021.01.010. Epub 2021 Mar 5.
The purpose of the study was to assess the relative clinical effectiveness of stent insertion with or without radioactive seed strand (RSS) insertion in patients suffering from malignant biliary obstruction (MBO).
Relevant articles published as of November 2020 in the Embase, PubMed, and Cochrane Library databases were identified and analyzed. Primary study endpoints for this meta-analysis were stent dysfunction, stent patency, and overall survival (OS), whereas secondary endpoints were rates of clinical success and complications. RevMan v5.3 was used to perform all meta-analyses.
In total, there were nine studies incorporating 643 patients (280 and 363 who underwent stent insertion with and without RSS, respectively). No differences were observed between these groups with respect to pooled rates of clinical success (p = 0.25), stent dysfunction (p = 0.47), cholangitis (p = 0.97), cholecystitis (p = 0.95), or pancreatitis (p = 0.66). However, stent patency duration (p < 0.00001) and patients' OS (p < 0.00001) were significantly increased in patients in the stent + RSS group. No heterogeneity was detected for any of these endpoints, nor did funnel plots yield any publication bias. A subgroup analysis of patients with hilar MBO similarly exhibited stent + RSS insertion to be associated with longer stent patency and OS as compared with stent insertion alone.
These findings showed that relative to stent insertion, stent + RSS insertion is associated with longer OS and stent patency in patients with inoperable MBO.
本研究旨在评估在患有恶性胆道梗阻(MBO)的患者中,支架置入术联合或不联合放射性种子strand(RSS)置入术的相对临床疗效。
截至 2020 年 11 月,在 Embase、PubMed 和 Cochrane Library 数据库中检索并分析了已发表的相关文章。本荟萃分析的主要研究终点是支架功能障碍、支架通畅率和总生存率(OS),次要终点是临床成功率和并发症发生率。使用 RevMan v5.3 进行所有荟萃分析。
共有 9 项研究纳入了 643 名患者(分别有 280 名和 363 名患者接受了支架置入术联合和不联合 RSS 治疗)。这两组患者在临床成功率(p=0.25)、支架功能障碍(p=0.47)、胆管炎(p=0.97)、胆囊炎(p=0.95)或胰腺炎(p=0.66)的总体发生率方面无差异。然而,支架通畅时间(p<0.00001)和患者 OS(p<0.00001)在支架+RSS 组显著延长。对于这些终点均未检测到异质性,漏斗图也未显示任何发表偏倚。对于肝门部 MBO 患者的亚组分析同样显示,与单独支架置入术相比,支架+RSS 置入术与更长的支架通畅时间和 OS 相关。
这些发现表明,与支架置入术相比,在无法手术的 MBO 患者中,支架+RSS 置入术与更长的 OS 和支架通畅率相关。